Rating History for NovaBay Pharmaceuticals (nby) by Roth/MKM

More Stocks Rated by Roth/MKM | Latest Ratings for nby
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/15/2018 N/A Maintain Neutral
(N/A)		 3.75
(4.00)		  
 		   Details